We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




7T MRI Used in Brain Disorder Research Collaboration

By LabMedica International staff writers
Posted on 16 Nov 2011
A 7-T magnetic resonance imaging (MRI) investigational scanner will be used to support academic research on functional brain mapping, high-resolution anatomic imaging of the brain, spectroscopy of the brain, assessment of tumor response to treatment, and cardiovascular imaging.

GE Healthcare (Chalfont St. More...
Giles, UK) and University of Iowa Health Care (Iowa City, USA) announced that they would collaborate on ultra-high-field MRI to study brain disorders. The purchase of the GE equipment for research use will be funded with a National Institutes of Health (NIH) high-end instrumentation grant awarded to Vincent Magnotta, PhD, in the department of radiology at University of Iowa Hospitals and Clinics in Iowa City (IA, USA).

The GE 7 T MR imaging scanner will provide ultra-high-field whole body scanning capabilities for MRI research. It will be housed in the University’s new Pappajohn Biomedical Discovery Institute, currently under construction. It is being acquired by the University of Iowa to support the research efforts of 33 funded US National Institutes of Health (NIH; Bethesda, MD, USA) investigators from five colleges (medicine, engineering, public health, liberal arts and sciences, and business) with more than 40 NIH grants. This group of researchers from University of Iowa has a wide range of interests including functional brain mapping, high-resolution anatomical imaging of the brain, spectroscopy of the brain, evaluation of tumor response to treatment, and cardiovascular imaging.

“We are honored and delighted to work with the University of Iowa to provide ultra-high-field strength MR imaging capabilities to help study patients with a variety of brain disorders,” said Jacques Coumans PhD, general manager of GE Healthcare’s MRI business. “Our 7 T MRI research system has the abilities to provide increased image resolution and sensitivity to help accelerate translational research. This collaboration is an excellent representation of how academic-industrial partnerships can help define new directions with the goal of facilitating more immediate health improvements and better outcomes.”

Three medical device vendors participated in a competitive proposal process for the research scanner purchase.

Related Links:
GE Healthcare
University of Iowa Health Care



Gold Member
Serological Pipets
INTEGRA Serological Pipets
Portable Electronic Pipette
Mini 96
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.